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Abstract
Background: Streptomyces viridochromogenes Tu«57 is the
producer of avilamycin A. The antibiotic consists of a heptasac-
charide side chain and a polyketide-derived dichloroisoeverninic
acid as aglycone. Molecular cloning and characterization of the
genes governing the avilamycin A biosynthesis is of major interest
as this information might set the direction for the development of
new antimicrobial agents.
Results : A 60-kb section of the S. viridochromogenes Tu«57
chromosome containing genes involved in avilamycin biosynthesis
was sequenced. Analysis of the DNA sequence revealed 54 open
reading frames. Based on the putative function of the gene
products a model for avilamycin biosynthesis is proposed.
Inactivation of aviG4 and aviH, encoding a methyltransferase
and a halogenase, respectively, prevented the mutant strains from
producing the complete dichloroisoeverninic acid moiety resulting
in the accumulation of new antibiotics named gavibamycins.
Conclusions : The avilamycin A biosynthetic gene cluster
represents an interesting system to study the formation and
attachment of unusual deoxysugars. Several enzymes putatively
responsible for specific steps of this pathway could be assigned.
Two genes encoding enzymes involved in post-PKS tailoring
reactions were deleted allowing the production of new analogues
of avilamycin A. ß 2001 Elsevier Science Ltd. All rights re-
served.
Keywords: Avilamycin; Gavibamycin; Orthosomycin; Methyltransferase;
Halogenase
1. Introduction
The emergence of pathogenic bacteria, which are resis-
tant to multiple antibiotics, represents a growing threat to
human health and has given additional impetus to the
search for new drugs [1]. Fewer and fewer new drugs
have been found in target screening programs during the
past two decades, and scientists have started to look for
new technologies to generate new compounds. One new
promising technology is named combinatorial biosynthe-
sis, which uses biosynthetic genes as tools to develop new
drugs [2]. The orthosomycins are a prominent class of
antibiotics produced by various actinomycetes [3]. Mem-
bers of this class are active against a broad range of
Gram-positive pathogenic bacteria including glycopep-
tide-resistant enterococci, methicillin-resistant staphylo-
cocci and penicillin-resistant streptococci [4^6]. Prominent
examples of orthosomycins are the avilamycins [7] (Fig. 1)
and the everninomicins [8] produced by Streptomyces vir-
idochromogenes Tu«57 and Micromonospora carbonacea, re-
spectively. Structural features common to these antibiotics
1074-5521 / 01 / $ ^ see front matter ß 2001 Elsevier Science Ltd. All rights reserved.
PII: S 1 0 7 4 - 5 5 2 1 ( 0 1 ) 0 0 0 4 0 - 0
* Correspondence: A. Bechthold;
E-mail : andreas.bechthold@uni-freiburg.de
CHBIOL 105 5-6-01
Chemistry & Biology 8 (2001) 569^581
www.elsevier.com/locate/chembiol
Table 1
Deduced functions of the ORFs in Fig. 2
Polypeptide
(gene)
Sequence similarity Proposed function Accession
number
Reference
AviX1 GTP-binding protein from M. tuberculosis Unknown AL021897 [40]
AviX2 Protein of unknown function from S. coelicolor A3(2) Unknown Y17736 [14]
AviX3 Protein of unknown function from S. coelicolor A3(2) Unknown Y17736 [14]
AviX4 ^ Unknown
AviX5 ^ Unknown
AviRb rRNA-methyltransferase from Chlamydia trachomatis Resistance AF317790 [10]
AviX6 ^ Unknown
AviX7 ^ Unknown
AviX8 ^ Unknown
AviRa ^ Resistance [10]
AviQ1 UDP-glucose 4-epimerase from T. maritima Sugar biosynthesis AE001727 [17]
AviGT2 Glycosyltransferase (Cps2J) from S. suis Biosynthesis of the heptasaccharide chain AF118389 [28]
AviX9 Hypothetical protein (SCF55.28c) from S. coelicolor A(3)2 Unknown AL132991 [14]
AviC1 Putative two-component response regulator from S. aureus Regulation AB035448 [37]
AviC2 Putative response regulator from S. noursei Regulation AF263912 [38]
AviX10 ^ Unknown
AviX11 ^ Unknown
AviG1 TylCIII from S. fradiae Sugar-biosynthesis (2-deoxy-D-evalose) AF147704 [25]
AviJ Putative Na/H antiporter from Amycolatopsis orientalis Antibiotic transport D90902 [36]
AviN DpsC from Streptomyces peucetius ATCC29050 Orsellinic acid biosynthesis L35560 [9]
AviM 6-methylsalicylic acid synthase from Penicillium patulum Orsellinic acid biosynthesis X55776 [9]
AviD dTDP-glucose synthetase from S. griseus Sugar biosynthesis (D-olivose, 2-deoxy-D-evalose) A26984 [9]
AviE1 dTDP-glucose 4,6-dehydratase from S. spectabilis Sugar biosynthesis (D-olivose, 2-deoxy-D-evalose) AF128272 [9]
AviQ2 UDP-glucose 4-epimerase from T. maritima Sugar biosynthesis AE001727 [17]
AviG5 Putative methyltransferase from Aeropyrum pernix K1 Modi¢cation (methylation) AP000064 [52]
AviO1 L-proline 4-hydroxylase from Dactylosporangium sp. C^O^C formation D78338 [32]
AviGT1 Glycosyltransferase from S. nogalater Biosynthesis of the heptasaccharide chain AF077869 [24]
AviE2 dTDP-glucose 4,6-dehydratase from S. coelicolor A(3)2 Sugar biosynthesis AL034492 [14]
AviG2 Putative methyltransferase from D. radiodurans Modi¢cation (methylation) AE001866 [29]
AviZ1 Putative oxidoreductase from P. aeruginosa PA01 Sugar biosynthesis AE004542 [16]
AviG6 L-isoaspartate O-methyltransferase from A. pernix K1 Modi¢cation (methylation) AP000064 [52]
AviO3 SnoK from S. nogalater C^O^C formation AF187532 [34]
AviG3 Protein of unknown function from Rhodococcus erythropolis Modi¢cation (methylation) U17129 [53]
AviX12 EryCV from S. erythraea Unknown U77459,
Y11199
[38,39]
AviABC1 DrrA from S. peucetius Antibiotic transport M73758 [9]
AviABC2 DrrB from S. peucetius Antibiotic transport M73758 [9]
AviB1 Pyruvate dehydrogenase (K chain) from C. magnum Modi¢cation L31844 [27]
AviB2 Pyruvate dehydrogenase (L chain) from C. magnum Modi¢cation L31844 [27]
AviGT3 Putative rhamnosyltransferase from Pyrococcus abyssi Biosynthesis of the heptasaccharide chain AJ248286 [29]
AviGT4 Putative mannosyltransferase (WbaZ-2) from A. fulgidus Biosynthesis of the heptasaccharide chain AE001063 [31]
AviO2 L-proline 4-hydroxylase from Dactylosporangium sp. C^O^C formation D78338 [32]
AviP p-nitrophenyl phosphatase from Halobacterium sp. NRC-1 Sugar biosynthesis (L-lyxose) AE005027 [26]
AviQ3 SpcI from S. £avopersicus Sugar biosynthesis Z95436 [18]
AviH PltA from P. £uorescens Pf-5 Modi¢cation (halogenation) AF081920 [12]
AviX13 ^ Unknown
AviG4 O-Demethylpuromycin O-methyltransferase from
S. alboniger
Modi¢cation (methylation) M74560 [11]
AviE3 dGDP-mannose-4,6-dehydratase from S. noursei
ATCC 11455
Sugar biosynthesis (4-O-methyl-D-fucose) AF317224 [15]
AviS Putative 2,3-dehydratase from S. argillaceus Sugar biosynthesis (D-olivose, 2-deoxy-D-evalose) AJ007932 [20]
AviT Putative 3-ketoreductase from S. argillaceus Sugar biosynthesis (D-olivose, 2-deoxy-D-evalose) AJ007932 [20]
AviZ3 Putative 4-ketoreductase (SnoG) from S. nogalater Sugar biosynthesis (D-olivose, 2-deoxy-D-evalose) AJ224512 [24]
AviZ2 Putative oxidoreductase from S. lividans Sugar biosynthesis Y18817 [14]
AviX14 Putative helicase from S. coelicolor A(3)2 Unknown AL132824 [14]
AviX15 Putative DNA-binding protein from S. coelicolor A(3)2 Unknown AL035212 [14]
AviX16 Alkaline serine protease from the marine bacterium
Alteromonas sp. strain O-7
Unknown AL359949 [42]
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are a terminal dichloroisoeverninic acid unit (residue A in
Fig. 1), D-olivose moieties (residues B and C), a 2-deoxy-D-
evalose moiety (residue D), a D-fucose moiety (residue E),
a D-mannose moiety (residue F), a L-lyxose moiety (residue
G) and a methyleurekanate moiety (residue H) [3]. These
residues are partly associated by orthoester linkages. Early
genetic work on the avilamycin biosynthetic gene cluster
revealed the presence of a NDP-glucose synthase gene
(aviD), a NDP-glucose 4,6-dehydratase gene (aviE1) and
a polyketide synthase gene (aviM). The deduced amino
acid sequence of aviM showed that this polyketide syn-
thase is an unusual multifunctional protein belonging to
iterative type I polyketide synthases. Expression of aviM
in Streptomyces lividans led to the formation of orsellinic
acid, an intermediate in the biosynthesis of dichloroiso-
everninic acid [9]. Recently, we reported the cloning and
characterization of two rRNA-methyltransferase genes
(aviRa and aviRb) and the ABC transporter genes avi-
ABC1 and aviABC2 which confer avilamycin resistance
when expressed in S. lividans [10]. The sequence and the
deduced functional analysis of the complete biosynthetic
cluster as well as the characterization of two genes aviG4
and aviH is the subject of the present report.
2. Results
2.1. Cloning and sequencing of approximately 60 kb of the
avilamycin cluster
Earlier work demonstrated that the NDP-glucose 4,6-
dehydratase gene aviE1 and the orsellinic acid synthase
gene aviM are involved in the biosynthesis of avilamycin
A [9]. Given the precedent for the clustering of related
biosynthetic genes in actinomycetes we proceeded to iso-
late and sequence DNA £anking the aviE1 and aviM genes
in order to identify the entire avilamycin biosynthetic gene
cluster. A 17.6-kb section of the avilamycin biosynthetic
gene cluster located upstream of aviM and a 35.9-kb sec-
tion located downstream of aviE1 were sequenced. Se-
quenced genes and the actual or putative function of their
gene products are listed in Table 1. Fig. 2 shows the ge-
netic organization of the avilamycin biosynthetic gene
cluster. The boundaries of the avi gene cluster have not
been determined by experiments, but it is reasonable to
propose that the cluster is £anked by an avilamycin resis-
tance gene (aviRb) and a putative deoxysugar biosynthetic
gene (aviZ2).
2.2. Genes putatively involved in dichloroisoeverninic acid
biosynthesis
AviM is responsible for orsellinic acid formation during
avilamycin biosynthesis. AviN, located upstream of aviM,
might encode an enzyme controlling the starter unit for
orsellinic acid synthesis [9]. As the biosynthesis of dichloro-
isoeverninic acid (residue A in Fig. 1) from orsellinic acid
requires methylation and di-halogenation, it was reason-
able to suggest that AviG4, resembling DmpM, an O-de-
methylpuromycin O-methyltransferase from Streptomyces
alboniger [11] (44% identical aa) and AviH, which is sim-
ilar to PltA, a halogenase from Pseudomonas £uorescens
Pf-5 involved in pyoluteorin biosynthesis [12] (39% identi-
cal aa), are responsible for modifying orsellinic acid.
Fig. 1. Structure of avilamycin A, avilamycin C, gavibamycin A1, gavibamycin A3, gavibamycin B1 and gavibamycin B3. (A) Dichloroisoeverninic acid,
(B, C) D-olivoses, (D) 2-deoxy-D-evalose, (E) 4-O-methyl-D-fucose, (F) 2,6-di-O-methyl-D-mannose, (G) 2-O-isobutyryl-L-lyxose, (H) methyleurekanate.
Orthoester linkages and one methylene bridge are marked by arrows.
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2.3. Putative deoxysugar biosynthetic genes
Surprisingly, the avilamycin biosynthetic gene cluster
contains six genes (aviE1, aviE2, aviE3, aviQ1, aviQ2,
aviQ3) that appear to encode either putative NDP-hexose
4,6-dehydratases or putative NDP-hexose epimerases. The
gene product of aviE1 is most similar to a dTDP-glucose
4,6-dehydratase from Streptomyces spectabilis [13] (59%
identical aa), and AviE2 is resembling a dNDP-glucose
4,6-dehydratase from Streptomyces coelicolor [14] (54%
identical aa). AviE3 shares 61% identical aa with NysDIII
from Streptomyces noursei [15] and 51% identical aa with a
dGDP-mannose 4,6-dehydratase from Pseudomonas aeru-
ginosa [16]. The proteins encoded by aviQ1 and aviQ2 are
most similar to an UDP-glucose 4-epimerase from Ther-
motoga maritima [17] (AviQ1: 43% identical aa; AviQ2:
38% identical aa), and AviQ3 resembles a putative epimer-
ase (SpcI) from Streptomyces £avopersicus [18] (44% iden-
tical aa). In the case of AviE2, AviQ1, AviQ2, and AviQ3
the exact function is di⁄cult to predict. The gene product
of aviE1 shows the highest degree of similarity to NDP-
hexose 4,6-dehydratases known to be involved in the for-
mation of 6-deoxysugars as components of antibiotics.
Therefore we expect that AviE1, together with AviD,
which is 62% identical to a NDP-glucose synthetase
from Streptomyces griseus [19], is involved in the early
steps of D-olivose (residue B and residue C in Fig. 1)
and 2-deoxy-D-evalose biosynthesis (residue D in Fig. 1).
The product of the aviS reading frame resembles proteins
identi¢ed as NDP-hexose 2,3-dehydratases in various spe-
cies. Highest homology is found to a putative NDP-hexose
2,3-dehydratase from Streptomyces argillaceus [20] (53%
identical aa). Downstream of aviS we found aviT. Homol-
ogy of the deduced 337 amino acids gene product suggests
that aviT encodes an oxidoreductase, since signi¢cant sim-
ilarity is found to the product of lanT, an oxidoreductase
homologue of Streptomyces cyanogenus (52% identical aa)
[21], to Gra-orf26 of Streptomyces violaceoruber (50%
identical aa) [22], and to an oxidoreductase from Amyco-
latopsis mediterranei (49% identical aa) [23]. Database
comparison of AviZ3 revealed close similarity to proteins
of di¡erent origin which act as (or presumably are) NDP-
hexose 4-ketoreductases. Highest homology is found to
SnoG, a NDP-hexose 4-ketoreductase homologue from
Streptomyces nogalater [24] (44% identical aa). AviS,
AviT and AviZ3 are most likely to be involved in the
conversion of NDP-4-keto-6-deoxy-D-glucose into NDP-
D-olivose. 2-Deoxy-D-evalose di¡ers from D-olivose in a
methyl group at position C3. We assume that NDP-4-
keto-2,6-dideoxy-D-glucose is a key intermediate in the
biosynthesis of this methylated deoxysugar. Methylation
by AviG1, mostly resembling TylCIII, a 3-C-methyltrans-
ferase from Streptomyces fradiae [25] (54% identical aa),
and ketoreduction by either AviZ1 or AviZ2, which both
resemble putative oxidoreductases (AviZ1 is most similar
to a putative oxidoreductase from P. aeruginosa (38%
identical aa) [16] and AviZ2 resembles a putative oxidore-
ductase from S. coelicolor A3(2) (70% identical aa) [14]),
are completing the biosynthesis. GDP-D-mannose (residue
F in Fig. 1) most probably derives from L-fructose-6-phos-
phate. Genes encoding enzymes involved in the conversion
of L-fructose-6-phosphate to GDP-D-mannose are not lo-
cated within the avilamycin cluster, and this has also been
reported for the biosynthesis of the nystatin deoxysugar
moiety, mycosamine [15]. AviE3 might convert GDP-man-
nose to GDP-4-keto-6-deoxy-D-mannose as the ¢rst inter-
mediate of GDP-D-fucose biosynthesis. Further conversion
to GDP-D-fucose might then be catalyzed by AviZ1 or
AviZ2 (4-ketoreduction) and AviQ1, AviQ2 or AviQ3
(2-epimerization). The biosynthesis of L-lyxose might start
from D-ribose-5-phosphate which is a product of the pen-
tose phosphate pathway. Conversion of D-ribose-5-phos-
Fig. 2. Genetic organization of the avilamycin biosynthetic gene cluster. Genes, belonging to the cluster, are indicated as dark arrows orientated in the
direction of transcription. Genes, probably located outside the cluster, are shown as light arrows (B, BamHI).
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phate to L-lyxose requires dephosphorylation and epime-
rization. The gene product of aviP1 resembles Pho2, a p-
nitrophenyl phosphatase from Halobacterium sp. NRC-1
(34% identical aa) [26] and a putative hydrolase from S.
coelicolor A3(2) (28% identical aa) [14]. Therefore AviP1
might be the responsible dephosphatase involved in D-lyx-
ose biosynthesis. The epimerization steps might then be
catalyzed by either AviQ1, AviQ2 or AviQ3. Residue H
can also be seen as a D-fucose moiety which again could be
derived from GDP-D-mannose. After 2-epimerization by
AviQ1, AviQ2 or AviQ3 and 4,6-dehydration (AviE2)
GDP-4-keto-6-deoxy-D-glucose might be produced. The
¢nal step of methyleurekanate biosynthesis might then
be accomplished by AviB1 and AviB2 which both resem-
ble enzyme components of various 2-oxo-acid dehydroge-
nase complexes. The gene product of aviB1 mostly resem-
bles the K-chain (45% identical aa), and AviB2 the L-chain
of an acetoin dehydrogenase (42% identical aa) from Clos-
tridium magnum [27]. We assume AviB1 and AviB2 to be
catalyzing the oxidative decarboxylation of pyruvate to
yield acetate and also the attachment of acetate to even-
tually produce this sugar derivative.
2.4. Genes putatively involved in the formation of the
heptasaccharide chain
We have identi¢ed four putative glycosyltransferase
genes in the cluster. The deduced protein of aviGT1 is
similar to glycosyltransferases known to be involved in
antibiotic biosynthesis. It mostly resembles SnoZ, a glyco-
syltransferase from Streptomyces nogalater [24] (41% iden-
tical aa). The deduced amino acid sequences of all other
putative glycosyltransferases found in the cluster were sim-
ilar to glycosyltransferases assigned to the biosynthesis of
O-antigen oligosaccharides. AviGT2 is similar to a puta-
tive glycosyltransferase (Cps2J) from Streptococcus suis
serotype 2 [28] (25% identical aa). The aviGT3 gene prod-
uct shows signi¢cant similarity to putative rhamnosyl-
transferases. Most similar are a rhamnosyltransferase
from Deinococcus radiodurans R1 (31% identical aa) [29]
and a rhamnosyltransferase from Streptococcus pneumo-
niae type 19B (29% identical aa) [30]. AviGT4 appears to
encode a mannosyltransferase as it resembles putative
mannosyltransferases from di¡erent species. Most similar
is WbaZ-2 from Archaeoglobus fulgidus (29% identical aa)
[31]. Three genes in the cluster (aviO1, aviO2 and aviO3)
all resemble a putative K-ketoglutarate-dependent L-pro-
line 4-hydroxylase from Dactylosporangium sp. [32],
HtxA, an K-ketoglutarate-dependent hypophosphite di-
oxygenase from Pseudomonas stutzeri WM88 [33] and
SnoK from S. nogalater [34]. AviO1 and AviO2, which
share 36% identical aa, are most similar to the L-proline
oxygenase (AviO1: 31% identical aa; AviO2: 29% identi-
cal aa), and AviO3 mostly resembles SnoK (30% identical
aa). All enzymes contain the motif HxD strongly con-
served in K-ketoglutarate-dependent enzymes. We specu-
late that AviO1, AviO2 and AviO3 are involved in the
formation of both orthoester linkages and the O^CH2^O
group (residue H in Fig. 1) of avilamycin A.
2.5. Genes putatively involved in tailoring the
heptasaccharide chain
Apart from aviG1, aviG4, aviRa and aviRb four further
putative methyltransferase genes (aviG2, aviG3, aviG5 and
aviG6) were found in the cluster. They were identi¢ed as
putative methyltransferase genes since either their prod-
ucts resemble methyltransferases from di¡erent organisms
or they contain motifs which are found in various meth-
ylating proteins [35]. Several avilamycin derivatives, which
do not contain methyl groups at di¡erent positions of the
molecule, are produced by our strain indicating that meth-
ylation occurs at a very late stage of the biosynthesis.
AviG2, AviG3, AviG5 and AviG6 might incorporate
methyl groups at the D-fucose moiety (residue E in Fig.
1), D-mannose moiety (residue F in Fig. 1) and methyl-
eurekanate moiety (residue H in Fig. 1) of avilamycin A.
2.6. Regulatory and resistance genes
As described recently aviRa, aviRb, aviABC1 and avi-
ABC2 are involved in avilamycin resistance or avilamycin
transport [10]. A further putative transporter gene is aviJ.
Its deduced amino acid sequence shows homology to pu-
tative integral membrane ion transporters. Highest resem-
blance was found to a Na/H antiporter from Synecho-
cystis sp. Strain PCC6803 [36] (49% identical aa). Two
putative regulatory genes were found in the cluster. The
deduced amino acid sequence of aviC1 and aviC2 are sim-
ilar to transcriptional activators of the response regulator
type. AviC1 closely resembles a response regulator from
Staphylococcus aureus [37] (31% identical aa), and AviC2
is most similar to Orf4 from S. noursei ATCC 11455 [15]
(27% identical aa).
2.7. Genes of unknown function
AviX8 resembles a hypothetical protein from S. coeli-
color with 34% identical aa [14]. AviX12 shows a signi¢-
cant degree of similarity to EryCV, a protein with un-
known function located in the erythromycin biosynthetic
gene cluster from Saccharopolyspora erythraea [38,39]
(28% identical aa). The putative gene products of short
open reading frames (ORFs) aviX4, aviX5, aviX6, aviX7,
aviX8, aviX10, aviX11 and aviX13 do not resemble any
protein in the databases.
2.8. Genes putatively located outside the cluster
Five putative ORFs (aviX1, aviX2, aviX3, aviX4, aviX5)
were found to reside close to the margin on one side of the
cluster and three putative ORFs (aviX14, aviX15, aviX16)
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near the opposite margin of the cluster. They probably do
not belong to the avilamycin biosynthetic gene cluster.
AviX1 is a GTP-binding protein with 64% identical aa
to a GTP-binding protein from Mycobacterium tuberculo-
sis [40]. AviX2 and AviX3 resemble proteins found in the
genome of S. coelicolor [14]. These ORFs with unknown
function are clustered in S. coelicolor and are located
downstream of a putative NAD synthase gene (nadE)
and upstream of a putative glutamate-ammonia-ligase ad-
enyltransferase gene (glnE) [41]. The deduced amino acid
sequence of aviX14 is similar to a putative helicase from S.
coelicolor [14] (32% identical aa), aviX15 encodes a puta-
tive DNA-binding protein similar to a protein from S.
coelicolor [14] (52% identical aa), and AviX16 might be
an alkaline serine protease very similar to a protease
from the marine bacterium Alteromonas sp. strain O-7
[42] (43% identical aa).
2.9. Generation of an aviG4 gene replacement mutant
For inactivation of aviG4 plasmid pMIKG4E3 was con-
structed allowing the replacement of the wild-type gene by
a mutated allele. After S. viridochromogenes Tu«57 proto-
plasts were transformed with plasmid pMIKG4E3, eryth-
romycin-resistant colonies were obtained. The transforma-
tion e⁄ciency was about 10 colonies per Wg plasmid DNA.
Numerous colonies were grown without erythromycin to
select for loss of resistance. Several sensitive colonies were
obtained suggesting that they were the consequence of a
double cross-over. Two mutants, named G4/24/20 and G4/
24/30, were further examined. PCR-fragments, ampli¢ed
from G4/24/20 and G4/24/30 DNA using primers aviG4F
and aviG4R, could not be digested by NcoI, whereas
PCR-fragments obtained from the wild-type DNA could
be cut by this enzyme. To con¢rm the presence of the
deletion within aviG4 Southern blot analysis was per-
formed as follows. NcoI-digested chromosomal DNA
was prepared from G4/24/20, G4/24/30 and the wild-type
strain. When probed with a 1.9-kb fragment containing
the entire gene aviG4 a 11-kb fragment was detected while
the expected 5-kb and 6-kb fragments could be identi¢ed
in the S. viridochromogenes Tu«57 strain (data not shown).
Mutant G4/24/30, now named S. viridochromogenes GW4,
was used for further experiments.
2.10. Generation of an aviG4^aviH double gene replacement
mutant
To knock out the aviH gene the inactivation plasmid
pSP1S2Nar was constructed. S. viridochromogenes GW4
protoplasts were transformed with this plasmid. About
20 erythromycin-resistant colonies per Wg DNA were ob-
tained. Some were cultivated and screened for loss of
erythromycin resistance indicating a double cross-over
event. Mutant S. viridochromogenes GW4-AM1 was chos-
en for further investigations. A 1.34-kb PCR-fragment
obtained from S. viridochromogenes GW4-AM1 using
primers S2A and S2B could not be digested by NarI,
whereas the PCR-fragment obtained from S. viridochromo-
genes GW4 could be digested by the enzyme. The deletion
within aviH was con¢rmed by Southern blot analysis.
Chromosomal DNA from S. viridochromogenes GW4-
AM1 was digested with NarI and hybridized with a 3.7-
kb probe containing the gene aviH. As result a 5.7-kb
fragment was detected, while chromosomal DNA from
S. viridochromogenes GW4 showed the expected fragments
of 4.3 and 1.4 kb (data not shown).
2.11. Complementation of S. viridochromogenes GW4 and
S. viridochromogenes GW4-AM1
To determine clearly that the mutation event only af-
fected the desired genes and not other genes, aviG4 and
aviH were ligated behind the ermE* promoter, cloned into
the integration plasmid pSET152 and introduced by pro-
Fig. 3. Isotopic patterns of the main new derivatives produced by mu-
tant S. viridochromogenes GW4. (A) Gavibamycin A1, (B) gavibamycin
A3 and S. viridochromogenes GW4-AM1, (C) gavibamycin B1, (D)
gavibamycin B3.
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toplast transformation into the corresponding mutants.
Avilamycin A and C production and gavibamycin A1
and A3 production respectively were restored. Thus, we
could rule out any upstream or downstream e¡ects.
2.12. Formation of new avilamycin derivatives by
S. viridochromogenes GW4 and S. viridochromogenes
GW4-AM1
Avilamycin A ([M+Na] : 1425) and avilamycin C
([M+Na] : 1427) were detected in extracts of S. virido-
chromogenes Tu«57 by liquid chromatography (LC)-ESI-
MS analysis. They were detected as sodium adduct ions
([M+23] ). The observed distribution of the isotopic pat-
tern of the pseudomolecular ions was in accordance with
calculated values. With the assignment of molecular
masses avilamycin C was produced as main compound.
Due to their characteristic isotopic patterns higher re-
solved mass spectra showed that both compounds contain
two chlorine atoms. The molecular masses of the pseudo-
molecular ions detected as the respective sodium adduct
ions of two major compounds produced by S. viridochro-
mogenes GW4 were [M+Na] = 1411, and [M+Na] =
1413 (Fig. 3) indicating that aviG4 indeed encodes a
methyltransferase. Based on the fact that AviG4 mostly
resembles an O-demethylpuromycin methyltransferase we
concluded that AviG4 is involved in methylation of the
orsellinic acid moiety. The major products of mutant
S. viridochromogenes GW4 were isolated, ethylated by
treatment with ethyliodide, hydrolyzed using methanol
and hydrochloric acid, and treated with diazomethane
(Fig. 4). Reaction products were analyzed by GC-MS.
The peak at m/z 436 corresponds to the D-olivosyl-ester
of dichloro-di-O-ethyl-orsellinic acid and most of further
peaks (m/z 405, m/z 275, m/z 247) correspond to fragments
derived from the orsellinic acid moiety (Fig. 5). When
extracts of S. viridochromogenes Tu«57 were treated with
ethyliodide a molecular mass peak of m/z 422 was detected
(data not shown). This leads to the conclusion that the
di¡erence between avilamycin A (C) and the new deriva-
tive named gavibamycin A1 (A3) (Fig. 1) results from a
change in the structure of the orsellinic acid moiety.
Extracts of S. viridochromogenes GW4-AM1 were
also analyzed by LC-ESI-MS. The mass of the two
major avilamycin derivatives was [M+Na] = 1343 and
[M+Na] = 1345 (Fig. 3) which was leading to the conclu-
sion that the di¡erence between the mass of these new
derivatives and the mass of the major compounds pro-
duced by S. viridochromogenes GW4 resulted from the
absence of two chlorine atoms. This was con¢rmed by
comparing the isotopic patterns of the main derivatives
from mutant S. viridochromogenes GW4 with the isotopic
patterns of the main products of mutant S. viridochromo-
genes GW4-AM1 (Fig. 3). The new derivatives were
named gavibamycin B1 (avilamycin A analogue) and
gavibamycin B3 (avilamycin C analogue) (Fig. 1).
2.13. Biological properties of gavibamycin A3 and
gavibamycin B3
The antimicrobial spectra of gavibamycin A3 (the major
compound produced by mutant S. viridochromogenes
GW4) was determined and compared to the antimicrobial
spectra of avilamycin A by the broth microdilution meth-
od following the procedures outlined by the National
Committee for Clinical Laboratory Standards [43]. Both
metabolites Gavibamycin A3 as well as avilamycin A
showed antibiotic activity against Bacillus subtilis, S. aur-
eus ATCC6538, S. aureus ATCC6538P, S. aureus
ATCC29213, a chinolon-resistant S. aureus Q48-1.2.1,
Enterococcus faecalis ATCC29212, a glycopeptide-resis-
tant E. faecalis H-7-6 and S. pneumoniae ATCC49619.
Fig. 4. Reaction scheme for the treatment of avilamycin derivatives and gavibamycin derivatives for GC-MS analysis.
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Gavibamycin B3, the major compound produced by S.
viridochromogenes GW4-AM1 was tested against B. subti-
lis using the agar di¡usion test. Antibiotic activity could
be detected.
3. Discussion
In the work presented here we report the sequence of
the avilamycin biosynthetic gene cluster that spans about
60 kb and involves at least 46 ORFs. A detailed sequence
analysis of the avi gene set revealed several features that
support a proposed model of the biosynthetic pathway to
this complex oligosaccharide antibiotic (Fig. 6). The puta-
tive function of some of the sugar biosynthetic genes can
be explained as their deduced amino acid sequences resem-
ble proteins known to be involved in the biosynthesis of D-
olivose in other organisms. As described for the biosyn-
thesis of D-olivose in S. violaceoruber Tu«22 (granaticin
producer) [44] and S. fradiae (urdamycin producer) [45]
the biosynthesis starts from glucose-1-phosphate which is
converted to dTDP-D-olivose and dTDP-2-deoxy-D-eval-
ose by several enzymes (Fig. 6). A novel feature in the
avilamycin biosynthetic pathway involves the occurrence
of three di¡erent NDP-hexose 4,6-dehydratase genes. On
the basis of sequence homology AviE1 is a dTDP-glucose
4,6-dehydratase, and AviE3 is a GDP-mannose 4,6-dehy-
dratase indicating that the biosynthesis of some of the
basic sugar building blocks starts from di¡erent nucleo-
tide-linked hexose pools. Based on the structure of avila-
mycin A and supported by the putative function of some
gene products apparently the biosynthesis of L-lyxose even
starts o¡ from a third sugar pool as it is a product of the
pentose phosphate pathway. Residue H (Fig. 1) of avila-
mycin A has originally been described as methyleureka-
nate derived from 2,3-di-O-methylene-4,5-dihydroxyhexa-
noic acid [3]. However, the sequence analysis presented
here suggests that methyleurekanate is also the product
of a sugar biosynthetic pathway. Based on the putative
function of genes detected in the gene cluster a model
for the synthesis of each sugar component of avilamycin
A can be proposed (Fig. 6). However, the whole pathway
and especially the exact order for individual biosynthetic
steps has to be determined by future experiments.
Taking into account the number of sugar moieties in the
avilamycin molecule six glycosyltransferase genes are ex-
pected. Interestingly, only four have been found. A con-
ceivable explanation could be the involvement of one or
more glycosyltransferases in several attachment steps or
the involvement of glycosyltransferases encoded outside
the cluster. Three of the four glycosyltransferases resemble
rather glycosyltransferases for the biosynthesis of O-anti-
gen structures or cell wall polysaccharides which can be
explained by the polysaccharide-like structure of avilamy-
cin A.
The avi pathway exposes even more interesting features:
two orthoester linkages and one methylene bridge (marked
by arrows in Fig. 1). Considering the oxidative nature of
Fig. 5. EI mass spectrum of the D-olivosyl ester of dichloro-di-O-ethyl-orsellinic acid.
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these C^O^C arrangements, the putatively K-ketogluta-
rate-dependent oxygenases AviO1, AviO2 and AviO3
may catalyze the formation of these unique bonds. We
propose such enzymes to use molecular oxygen as the
direct electron acceptor for oxidation by using K-ketoglu-
tarate as a cosubstrate producing the ¢nal C^O^C bonds,
succinate and CO2. The avilamycin A heptasaccharide is
modi¢ed by methylation, attachment of acetate, attach-
ment of dichloroisoeverninic acid and attachment of an
isobutyryl moiety. Six methyltransferase genes appear to
be present in the cluster which is the adequate number for
avilamycin biosynthesis, whereas genes required for the
attachment of the other residues have not been located
yet. Interestingly, we found aviB1 and aviB2 encoding en-
Fig. 6. Proposed biosynthetic pathway of avilamycin A.
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zymes similar to the K and the L chain of components I
of 2-oxo acid dehydrogenase complexes. These complexes
are usually composed of three enzymatic units, which
are TPP-dependent dehydrogenases, heterotetramers
(K2L2), dihydrolipoamide acetyltransferases (homomultim-
ers) and dihydrolipoamide dehydrogenases (homodimers)
[27]. ORFs encoding the latter components of these
complexes are either not located inside the cluster or
are not required for the biosynthesis of avilamycin A at
all.
Members of the orthosomycin antibiotics are powerful
agents against many Gram-positive pathogenic microor-
ganisms, and some of them are promising antibiotics.
Anyway, they have not been developed so far as anti-
biotics against human infectious diseases for clinical use
because of some disadvantageous pharmacokinetic charac-
teristics. Structural modi¢cation of antibiotics has proven
to impart signi¢cant improvement in oral bioavailabil-
ity and more persistent serum/tissue levels of pharma-
ceuticals. Therefore we decided to apply molecular genetic
methods to alter the structure of the avilamycins with the
aim of generating new analogues. Two of the putative
modifying genes, aviG4 and aviH, were inactivated by
gene replacement. New antibiotics named gavibamycins
were produced by the corresponding mutants (Fig. 1).
These antibiotics consist of the entire heptasaccharide
chain and an orsellinic acid moiety which can occur in a
chlorinated (aviG4-mutant) or non-chlorinated form
(aviG4^aviH double mutant). S. viridochromogenes Tu«57
produces several avilamycin derivatives which di¡er in
their methylation pattern. However, a compound missing
the methyl group or both chlorine atoms at the aromatic
polyketide has never been described. Gavibamycin A3,
major compound of mutant S. viridochromogenes GW4,
and gavibamycin B3, major compound of mutant S. vir-
idochromogenes GW4-AM1, were tested against several
bacterial strains. Both compounds were active indicating
that the loss of the methyl group and both chlorine atoms
did not prevent the new derivatives from acting as anti-
biotics.
In addition gavibamycin A3 and gavibamycin B3 seem
to be much more hydrophilic than avilamycin A as indi-
cated by Rf-values obtained by TLC and by HPLC anal-
ysis. Our future work will revolve around creating new
avilamycin derivatives by targeted gene deletion or combi-
natorial biosynthesis approaches. This may eventually lead
us to pharmacokinetically improved members of this
promising antibiotic class.
4. Signi¢cance
The avilamycin biosynthetic gene cluster encodes a nov-
el pathway that yields the structurally interesting orthoso-
mycin antibiotic avilamycin A. Functional assignment to
the proteins encoded within the cluster suggests a model
for the complex avilamycin biosynthetic pathway. We
demonstrated that genetic manipulation of the avilamycin
cluster results in the production of new antibiotically ac-
tive avilamycin derivatives.
5. Materials and methods
5.1. Bacterial strains, plasmids and culture conditions
S. viridochromogenes Tu«57 [7] was grown on 1% malt extract,
0.4% yeast extract, 0.4% glucose and 1 mM CaCl2, pH adjusted
to 7.2 (HA medium) at 37‡C. For avilamycin production S. vir-
idochromogenes Tu«57 and all mutants were grown at 28‡C in
NL19+ medium containing 2% D-mannitol, 2% soy £our and
20 mM L-valine adjusted to pH 7.5. DNA manipulation was
carried out using Escherichia coli XL-1 Blue MRFP (Stratagene)
as host strain. Before transforming S. viridochromogenes Tu«57,
plasmids were propagated in E. coli ET 12567 (dam3, dcm3,
hsdS, CmR) [46] to obtain unmethylated DNA. E. coli strains
were grown on Luria^Bertani (LB) agar or liquid medium con-
taining the appropriate antibiotic. pBluescript SK- (pBSK-) and
pBC-SK- were from Stratagene. Plasmids pUC19 and pSP1 [9],
conferring erythromycin resistance, were a kind gift of Dr. S.
Pelzer, Tu«bingen and pSET152 [47], conferring apramycin resis-
tance, was obtained from Eli Lilly and Co. (Indianapolis, IN,
USA).
5.2. General genetic manipulation, PCR and DNA
sequencing/sequence analysis
Standard molecular biology procedures were performed as de-
scribed [48]. Isolation of E. coli plasmid DNA, DNA restriction,
DNA modi¢cation and Southern hybridization were performed
following the protocols of the manufacturers of kits, enzymes and
reagents (Amersham-Pharmacia, Roche Diagnostics, Promega,
Stratagene). Streptomyces protoplast formation, transformation
and protoplast regeneration were performed as described [49].
PCR was carried out using a Perkin Elmer GeneAmp 2400 ther-
mal cycler. The conditions were as described [50]. Oligonucleotide
primers used were AviG4F (5P-GGACGCCTATCTGTGC-
CACCCCTTCCTGGT-3P), AviG4R (5P-TGAGCGCTCGCC-
TAGACAGAATCATCTCCC3P), S2A (5P-GCGTCCATCTTG-
CCGGGA-3P) and S2B (5P-CGTGGATCCCGCCGGCCC-3P).
Nucleotide sequences were determined by the dideoxy chain-ter-
mination method using an automatic laser £uorescence sequencer
(Perkin Elmer ABI). Sequencing reactions were done using a
thermosequenase cycle sequencing kit with 7-deaza-dGTP (Amer-
sham) and standard primers (M13 universal and reverse, T3, T7).
Computer-aided sequence analysis was done with the DNASIS
software package (version 2.1, 1995; Hitachi Software Engineer-
ing), database searches were performed with the BLAST 2.0 pro-
gram [51] on the server of the National Center for Biotechnology
Information, Bethesda MD, USA. The sequence reported here
has been deposited in the GenBank data base under the accession
number AF333038.
CHBIOL 105 5-6-01
578 Chemistry & Biology 8/6 (2001) 569^581
5.3. Construction of gene inactivation plasmids
aviG4 : A unique NcoI restriction site inside the gene aviG4,
which is located on a 1.9-kb fragment ligated into the SacI and
EcoRI sites of pBSK- was chosen for targeted inactivation by
shifting the reading frame. The 1.9-kb fragment was digested
with SacI and KpnI and was ligated into the gene inactivation
plasmid pSP1. After NcoI restriction, treatment with the Klenow
fragment of E. coli DNA-polymerase I and religation, the in-
tended alteration (correct ¢ll-in) was con¢rmed by DNA sequenc-
ing. The generated plasmid was named pMIKG4E3.
aviH: The unique NarI site inside the aviH gene, which is
located on a 3.7-kb SacI fragment ligated into pBCSK-, was
altered by NarI restriction and subsequent treatment as described
for aviG4. Sequencing of several plasmids revealed correct alter-
ation. The 3.7-kb fragment was cloned into pSP1 to generate the
gene inactivation plasmid pSP1S2Nar.
5.4. Construction of complementation plasmids
pUWLurdGT1c [54] was subjected to a KpnI/XbaI restriction
digestion to obtain a 1.6 kb fragment that covers the complete
reading frame urdGT1c as well as the ermE* promoter sequence.
This fragment was inserted in the multiple cloning site of pUC19
cleaved with the same enzymes. This plasmid was named pUC19-
1cerm. Then, urdGT1c and the ermE* promoter were excised by
EcoRI restriction and ligated into pSET152 to create plasmid
pSET-1cerm. Both genes, aviG4 and aviH, were ampli¢ed using
PCR. Suitable restriction sites (aviG4, MunI and XbaI; aviH,
EcoRI and XbaI) were introduced using oligonucleotide primers
G4F (5P-AAGGACAATTGGCGACGAGA-3P), G4R (5P-
GCTCCTCTAGACGGTGAAAT-3P), aviHA (5P-GTATTTCA-
GAATTCCCCGTGCCGG-3P) and aviHB (5P-GCCCGGTCTA-
GACGCTGTGATCAGGG-3P) (restriction sites are underlined).
Plasmid pSET-1cerm was digested with MunI and XbaI to re-
move urdGT1c, and aviG4 and aviH, respectively, were cloned
behind the ermE* promoter in place of urdGT1c to create inte-
gration plasmids pSET-G4erm and pSET-Herm. After transfor-
mation of mutants S. viridochromogenes GW4 and S. viridochro-
mogenes GW4-AM1 with the corresponding integration plasmids
several apramycin-resistant colonies were obtained and grown at
28‡C in liquid medium as described above. Extracts of cultures
were analyzed by TLC or LC-ESI-MS.
5.5. Analysis of new derivatives of avilamycin A
5.5.1. TLC analysis
S. viridochromogenes Tu«57 and mutants S. viridochromogenes
GW4 and S. viridochromogenes GW4-AM1 were incubated for 3
days. Cultures were ¢ltered and the ¢ltrate was applied to a solid-
phase extraction cartridge (SepPak0C18, Waters). The cartridge
was eluted using a gradient from 10 to 100% methanol in water.
Avilamycin derivatives could be detected in fractions containing
60^70% methanol. After ethyl acetate extraction and evaporation
of the solvent avilamycin derivatives were redissolved in methanol
and analyzed by TLC on silica gel plates (silica gel 60 F254,
Merck) with methylene chloride/methanol (9:1, v/v) as solvent.
Avilamycin derivatives could be detected after treatment with
anisaldehyde/H2SO4.
5.5.2. HPLC-UV analysis
Analytical HPLC-UV was performed on a Hewlett Packard
1090 liquid chromatograph with a photodiode array detector
and an HP-ODS-Hypersil 5 Wm, 200U2 mm column. The detec-
tion wavelength was 210 nm. The solvent system was as follows:
solvent A, 0.04 M (NH4)2HPO4 pH 7.0 bu¡er; solvent B, 100%
methanol; non-linear gradient, 30^62% B in 25 min at a £ow rate
of 0.2 ml/min.
5.5.3. HPLC-ESI-MS analysis
For HPLC-ESI-MS analysis avilamycin derivatives were sepa-
rated by HPLC (HP1110, Hewlett-Packard) with a HP-ODS-Hy-
persil C18 column (100U2.1 mm; 5 Wm) at a £ow rate of 0.1 ml/
min, detection at 220 nm and following gradient: 0^5 min, linear
gradient to 20% B; 5.0^120 min, linear gradient to 90% B (sol-
vent A, H2O: MeOH 3:2; solvent B, MeOH). Mass spectra were
recorded on a Bruker Esquire-LC 1.6n mass spectrometer
(Bruker Daltonik) equipped with an electrospray ion source (pos-
itive ion mode) (ESI). The scan-range was from 200 to 1800 m/z
with nominal mass resolution.
5.5.4. GC-MS analysis
Analysis of new gavibamycin derivatives produced by mutant
S. viridochromogenes GW4 was performed by GC-MS analysis
after ethylation. The derivatives were dissolved in a mixture of
DMSO and acetonitrile (3:40). After addition of ethyliodide and
K2CO3 the reaction was incubated over night. After evaporation
of the solvent avilamycin derivatives were hydrolyzed by HCl/
methanol at 115‡C for 15 min. The solvent was evaporated again
and compounds were treated with diazomethane in ethanol (30
min at 20‡C). After evaporation of the solvent derivatives were
extracted with diethylether and analyzed by GC-MS. An Hewlett
Packard 5973 MSD system was used to obtain EI (electron im-
pact) spectra (column: SE54, 12 mU0.25 mm; df = 0.125 W). The
column temperature was programmed as follows: 50‡C for 2 min;
25‡C/min to 100‡C; 5‡C/min to 250‡C.
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